MATERA, Maria Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 6.629
EU - Europa 6.326
AS - Asia 1.120
SA - Sud America 18
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 7
Totale 14.123
Nazione #
US - Stati Uniti d'America 6.605
IE - Irlanda 1.955
UA - Ucraina 1.110
GB - Regno Unito 828
IT - Italia 739
DE - Germania 675
SG - Singapore 455
CN - Cina 361
FI - Finlandia 273
FR - Francia 239
GR - Grecia 221
SE - Svezia 187
TR - Turchia 157
HK - Hong Kong 44
KR - Corea 27
BE - Belgio 23
CA - Canada 19
ID - Indonesia 17
ES - Italia 15
JP - Giappone 14
NL - Olanda 12
RU - Federazione Russa 10
CL - Cile 8
EU - Europa 8
IL - Israele 8
IR - Iran 8
IN - India 7
MD - Moldavia 7
PL - Polonia 7
AU - Australia 6
CZ - Repubblica Ceca 6
PE - Perù 6
TW - Taiwan 6
AT - Austria 4
CH - Svizzera 4
ET - Etiopia 4
MX - Messico 3
AP - ???statistics.table.value.countryCode.AP??? 2
BR - Brasile 2
IQ - Iraq 2
MA - Marocco 2
SA - Arabia Saudita 2
TH - Thailandia 2
TM - Turkmenistan 2
VN - Vietnam 2
YE - Yemen 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KE - Kenya 1
LT - Lituania 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 14.123
Città #
Dublin 1.953
Jacksonville 1.714
Santa Clara 1.336
Chandler 756
Princeton 359
Medford 326
Singapore 269
Bremen 225
Roxbury 188
Boardman 182
San Mateo 158
Wilmington 139
Ann Arbor 102
Woodbridge 86
Beijing 84
Cambridge 77
Des Moines 70
Düsseldorf 49
Naples 45
Ashburn 44
Caserta 42
Hong Kong 41
New York 33
Norwalk 33
Jinan 29
Rome 26
Shanghai 23
Brussels 22
Seoul 20
Hebei 18
Napoli 18
Los Angeles 16
Mountain View 16
Zhengzhou 16
Nanjing 15
Redwood City 15
Shenyang 14
Bari 13
Auburn Hills 12
Houston 12
Dearborn 11
Haikou 11
Milan 11
Changsha 10
Alvignano 9
Casoria 9
Hangzhou 9
Hefei 8
Lanzhou 8
London 8
Padang 8
Strasbourg 8
Bologna 7
Chisinau 7
Monza 7
Salerno 7
Venice 7
Florence 6
Giv‘atayim 6
Groningen 6
Hanover 6
Helsinki 6
Lima 6
Marano Di Napoli 6
Nanchang 6
Ningbo 6
Scafati 6
Seattle 6
Taiyuan 6
Avellino 5
Guangzhou 5
Munich 5
Sant'Anastasia 5
Shenzhen 5
Taipei 5
Toronto 5
Turin 5
Barcelona 4
Catania 4
Fairfield 4
Hamilton 4
Menlo Park 4
Osaka 4
Padula 4
Piedimonte 4
Portici 4
St Petersburg 4
Taizhou 4
Tianjin 4
Tolentino 4
Akita 3
Benevento 3
Biella 3
Cagliari 3
Fuzhou 3
Giugliano In Campania 3
Grafing 3
Gunzenhausen 3
Gwangjin-gu 3
Hengyang 3
Totale 8.935
Nome #
Farmaci dell’Apparato Respiratorio: Regolazione del tono broncomotore. 329
Sistema purinergico. 274
“COPDCoRi: applicazione non invasiva per la stima e la previsione del rischio di patologia coronarica nei pazienti affetti da broncopneumopatia cronica ostruttiva (BPCO)”. 99
Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa 94
Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure. 76
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways. 70
Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis 70
Evidence of muscarinic receptor subtypes in airway smooth muscle of normal volunteers and of chronic obstructive pulmonary disease patients 70
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients. 69
Excitatory amino acids and cardiovascular apparatus: experimental studies on conscious rats with L-glutamate, N-methyl-D-aspartate, kainate and quisqualate 69
Flomoxef, a new oxacephem antibiotic, does not cause hemostatic defects 68
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi. 67
Effects of hyperbaric oxygen exposure on non-adrenergic non-cholinergic responses of rat trachea 67
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. 67
Intraulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections. 67
Prenatal and postnatal vanadium exposure in rats: effect on vasomotor reactivity development of pups 66
10. Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease. 65
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease. 64
A comparison of sensory nerve function in human, guinea-pig, rabbit and marmoset airways 64
Amminoacidi eccitatori e regolazione centrale della funzione cardiovascolare: contributi sperimentali. 64
Treatment of COPD: moving beyond the lungs. 64
Brain natriuretic peptide : much more than a biomarker 64
Effects of in vitro 5-HT1 receptor activation in guinea pig trachea 63
Farmaci per il trattamento delle aritmie cardiache. 63
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement 62
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study 61
Terapie per i disordini labirintici: effetti e riflessi sulla pressione arteriosa 61
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease 61
Ions and intracellular mechanisms involved in the effects of L-glutamate on arginine vasopressin release: in vitro researches on rat neurohypophysis 60
Bioavailability of timolol and aceclidine after ocular instillation in the rabbit 60
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 60
characterization of the Pharmacological interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. 59
Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease. 59
Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD. 59
1. New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol. 59
Protein Prenylation Contributes to the Effects of LPS on EFS-Induced Responses in Human Isolated Bronchi 59
Assessing the viability of long-acting β(2)-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective. 59
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease 58
K+ channels and guinea-pig trachea: a possible functional modulation by GABAB receptors 58
Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits 58
Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema 58
Nitric oxide regulatory role in sensitized guinea pig trachea 57
Evidence for non-adrenergic non-cholinergic contractile responses in bovine and swine trachea 57
Calcium dependence of the evoked arginine vasopressin release by electrical stimulation and by L-glutamate 56
Research on heterocyclic compounds. XIV - Imidazothiazole and imidazobenzothiazole derivatives: synthesis and antiinflammatory activity 56
Possible functional modulation by acetylcholine of nitric oxide on guinea pig isolated trachea 56
Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple therapy in COPD 56
Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease 55
Role of 5-hydroxytryptamine in mediating adenosine-induced airway contraction 55
Pharmacological Characterization of Adenosine Receptors on Isolated Human Bronchi 54
Serum digoxin levels after concomitant ticarcillin and clavulanic acid administration 54
Brain Natriuretic Peptide Protects Against Hyperreactivity of Human Asthmatic Airway Smooth Muscle via an Epithelial Cell Dependent Mechanism. 54
Prenatal and postnatal antimony exposure in rats: effect on vasomotor reactivity development of pups 54
N-acetylcysteine in COPD may be beneficial, but for whom? 54
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD 54
Farmaci per il trattamento della cardiopatia ischemica. 54
Treating systemic effects of COPD. 53
Role of 5-HT2 receptor subtypes in mediating adenosine-induced airway contraction 53
Teicoplanin with other drugs: possible pharmacological interactions 53
A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease 53
I farmaci dell'apparato gastrointestinale 53
Translational Study Searching for Synergy between Glycopyrronium and Indacaterol. 52
Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler 52
Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. 52
I farmaci del sistema nervoso centrale 52
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? 52
Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma 51
Effects of RO 5-4864 and PK 11195 on guinea pig trachea 51
LABAs in asthmatic children: highlights and new inside. 51
Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa 51
Long-acting bronchodilators are the first-choice option for the treatment of stable COPD 50
Functional role of nitric oxide in guinea pig tracheal epithelium 50
Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study 50
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination 50
Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study 49
Treatment of Chronic Obstructive Pulmonary Disease by Dual Bronchodilation with Coformulation of Indacaterol/Glycopyrronium. 49
Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents 49
Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough 49
Farmaci per il trattamento dello scompenso cardiaco. 49
Farmaci del sistema cardiovascolare, del sangue e del rene 49
Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi 49
Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease 48
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation. 48
Adenosine receptors: novel targets for drug development in allergic rhinitis 48
Fumo passivo ed infezioni batteriche a carico del tratto respiratorio inferiore 48
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma. 48
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus 48
Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children 47
. Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells. 47
β(2) -adrenoceptor agonists: current and future direction 47
Clinical pharmacokinetics of salmeterol 47
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPD 47
I farmaci dell’apparato gastroenterico 47
Impact of doxofylline in COPD: A pairwise meta-analysis 47
Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome 47
Fixed-Dose Combination Inhalers 47
Adherence to COPD treatment: Myth and reality 47
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 47
Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis. 46
Onset of action following formoterol Turbuhaler and salbutamol pMDI in reversible chronic airway obstruction 46
Totale 6.139
Categoria #
all - tutte 69.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020726 0 0 0 0 0 0 356 103 142 60 40 25
2020/20212.310 256 7 292 78 387 29 346 282 20 290 261 62
2021/20221.935 168 15 27 42 688 7 25 47 59 70 185 602
2022/20233.445 411 47 36 234 440 248 7 178 1.694 17 53 80
2023/20241.395 103 34 35 138 551 59 36 33 14 21 85 286
2024/20251.793 34 33 57 154 874 615 26 0 0 0 0 0
Totale 14.505